Added to YB: 2023-12-20
Pitch date: 2023-12-20
INTS:US [bullish]
Intensity Therapeutics, Inc.
-92.99%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States.
Market Cap
$34.2M
Pitch Price
$6.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.89
P/E
-1.91
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Intensity Therapeutics, Inc. INTS:US
A summary for this pitch has not been created yet.
Read full article (0 min)